Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coherus Oncology (CHRS) Tax Rate (2019 - 2023)

Historic Tax Rate for Coherus Oncology (CHRS) over the last 3 years, with Q3 2023 value amounting to 0.95%.

  • Coherus Oncology's Tax Rate changed N/A to 0.95% in Q3 2023 from the same period last year, while for Dec 2023 it was 0.16%, marking a year-over-year change of. This contributed to the annual value of 0.16% for FY2023, which is N/A changed from last year.
  • As of Q3 2023, Coherus Oncology's Tax Rate stood at 0.95%.
  • Coherus Oncology's 5-year Tax Rate high stood at 10.12% for Q4 2020, and its period low was 0.22% during Q2 2019.
  • Moreover, its 3-year median value for Tax Rate was 1.96% (2019), whereas its average is 2.93%.
  • Over the last 5 years, Coherus Oncology's Tax Rate had its largest YoY gain of 51700bps in 2020, and its largest YoY loss of -10600bps in 2020.
  • Over the past 3 years, Coherus Oncology's Tax Rate (Quarter) stood at 4.95% in 2019, then soared by 104bps to 10.12% in 2020, then tumbled by -91bps to 0.95% in 2023.
  • Its Tax Rate stands at 0.95% for Q3 2023, versus 10.12% for Q4 2020 and 0.71% for Q3 2020.